lactulose has been researched along with Scleroderma, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bortoli, N; Dulbecco, P; Furnari, M; Gemignani, L; Ghio, M; Giambruno, E; Negrini, S; Parodi, A; Savarino, E; Savarino, V; Zentilin, P | 1 |
| Bazzica, M; Filaci, G; Ghio, M; Greco, A; Indiveri, F; Parodi, A; Savarino, E; Savarino, V; Sessarego, M; Setti, M | 1 |
| Bei, L; Pan, G; Wang, J | 1 |
1 trial(s) available for lactulose and Scleroderma, Systemic
| Article | Year |
|---|---|
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Esophageal Motility Disorders; Esophagus; Female; Humans; Lactulose; Male; Manometry; Middle Aged; Scleroderma, Systemic; Time Factors; Young Adult | 2013 |
2 other study(ies) available for lactulose and Scleroderma, Systemic
| Article | Year |
|---|---|
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
Topics: Adult; Aged; Anti-Infective Agents; Blind Loop Syndrome; Breath Tests; Cross-Sectional Studies; Female; Gastrointestinal Transit; Humans; Intestine, Small; Lactulose; Male; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Scleroderma, Systemic; Treatment Outcome | 2008 |
[Lactulose hydrogen breath test in small intestinal bacterial overgrowth].
Topics: Adult; Bacteria, Anaerobic; Breath Tests; Female; Humans; Hydrogen; Intestine, Small; Lactulose; Male; Middle Aged; Scleroderma, Systemic; Syndrome | 1995 |